…
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Pomdoctor Limited (NASDAQ: POM) is a publicly listed company for which available public disclosures about its operations and market activities are limited, so its core business and industry exposure are not clearly documented in commonly accessible sources. Long-term growth drivers are not well-defined in public filings, but the stock could attract investors if the company provides fuller disclosures and demonstrates consistent revenue generation or execution on any stated strategic initiatives.
Material risks include limited and opaque public information, low trading liquidity, potential corporate governance and regulatory uncertainty typical of small or foreign-listed firms, and execution risk if operating results are not verifiable.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| POM POMDOCTOR LIMITED American Depositary Shares |
0.06 3.75% |
1.66 | - | - | - | - |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.